Home >
Medicine Info >
Ciclohale 200 mcg Rotacap
Loading interface...

Ciclohale 200 mcg Rotacap

Manufactured byCIPLA LTD
ContainsCiclesonide
Description
Ciclohale 200 mcg Rotacap is a corticosteroid that is used to relieve symptoms such as shortness of breath, wheezing, breathing difficulties, runny nose, sneezing, itchy nose, etc. associated with asthma and allergic rhinitis. This medicine is not recommended for use as the primary treatment for asthma.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Ciclohale 200 mcg Rotacap

  • Body pain
  • Headache
  • Sore throat
  • Dizziness
  • Fever
  • Unusual tiredness or weakness
  • Stuffy nose

Uses of Ciclohale 200 mcg Rotacap

What is it prescribed for?

  • Allergic Rhinitis
  • Asthma - Maintenance
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 24-48 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to ciclesonide or any other inactive ingredients present along with this medicine.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.
General warnings

Visual disturbance

This medicine may cause blurred vision or other visual disturbances in some patients. Report any such symptoms to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Growth retardation

This medicine may cause growth retardation in some children. Therefore, children receiving this medicine should be monitored closely with regard to growth parameters. The dose should be titrated to the minimum effective dose to reduce the chances of such side effects. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Glaucoma

This medicine should be used with caution in patients with pre-existing glaucoma due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Tuberculosis

This medicine should be used with extreme caution in patients suffering from tuberculosis due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Infections

This medicine should be used with caution in patients who are at risk of developing infections since it suppresses the immune system and further increases the risk of infections. Any symptoms such as a sore throat, fever, chills, etc. should be reported to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Use in pediatrics

The inhaler/rotacap form of this medicine is not recommended for use in patients below 12 years of age. The nasal spray form of this medicine is not recommended for use in patients below 6 years of age.

Driving or operating machinery

This medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Use the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Atazanavir

Amprenavir

Nefazodone

Itraconazole

Clarithromycin

Ritonavir

Disease interactions

Ocular herpes simplex

This medicine should be used with caution in patients with an ocular herpes infection due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Infections

This medicine should be used with extreme caution in patients with latent or active infections since this medicine can suppress the immune system and worsen the patient's condition. This risk is especially higher in patients on high doses of this medicine for a prolonged period of time. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Hyperadrenocorticism

This medicine should be used with caution in patients having a high level of adrenal hormones in the body due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Ocular Toxicities

This medicine should be used with extreme caution in patients with a history of cataracts, glaucoma, or increased intraocular pressure due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Inhaler/Nasal spray: Use this medicine exactly as advised by your doctor. Do not use in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by inhibiting the release of certain substances in the body that cause inflammation (swelling, redness, pain, etc.)
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Inhaled corticosteroids, Nasal steroids

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2018 [cited 20 March 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021658s006lbl.pdf

[Internet]. Medicines.org.uk. 2018 [cited 20 March 2018]. Available from:

https://www.medicines.org.uk/emc/files/pil.333.pdf

Ciclesonide - DrugBank [Internet]. Drugbank.ca. 2018 [cited 20 March 2018]. Available from:

https://www.drugbank.ca/drugs/DB01410

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2018 [cited 20 March 2018]. Available from:

https://www.tga.gov.au/prescribing-medicines-pregnancy-database

DailyMed - ciclesonide spray [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 29 March 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a131e33f-00dc-4601-88b3-ab19b24865ee
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 29 Mar 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.